196 related articles for article (PubMed ID: 27085458)
1. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
2. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of KIT in familial testicular germ cell tumours.
Rapley EA; Hockley S; Warren W; Johnson L; Huddart R; Crockford G; Forman D; Leahy MG; Oliver DT; Tucker K; Friedlander M; Phillips KA; Hogg D; Jewett MA; Lohynska R; Daugaard G; Richard S; Heidenreich A; Geczi L; Bodrogi I; Olah E; Ormiston WJ; Daly PA; Looijenga LH; Guilford P; Aass N; Fosså SD; Heimdal K; Tjulandin SA; Liubchenko L; Stoll H; Weber W; Einhorn L; Weber BL; McMaster M; Greene MH; Bishop DT; Easton D; Stratton MR
Br J Cancer; 2004 Jun; 90(12):2397-401. PubMed ID: 15150569
[TBL] [Abstract][Full Text] [Related]
4. Mutations of BRAF and RAS are rare events in germ cell tumours.
Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors.
McIntyre A; Summersgill B; Spendlove HE; Huddart R; Houlston R; Shipley J
Neoplasia; 2005 Dec; 7(12):1047-52. PubMed ID: 16354586
[TBL] [Abstract][Full Text] [Related]
6. An unusual phenotype of Frasier syndrome due to IVS9 +4C>T mutation in the WT1 gene: predominantly male ambiguous genitalia and absence of gonadal dysgenesis.
Melo KF; Martin RM; Costa EM; Carvalho FM; Jorge AA; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Jun; 87(6):2500-5. PubMed ID: 12050205
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
Looijenga LH; de Leeuw H; van Oorschot M; van Gurp RJ; Stoop H; Gillis AJ; de Gouveia Brazao CA; Weber RF; Kirkels WJ; van Dijk T; von Lindern M; Valk P; Lajos G; Olah E; Nesland JM; Fosså SD; Oosterhuis JW
Cancer Res; 2003 Nov; 63(22):7674-8. PubMed ID: 14633689
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract][Full Text] [Related]
10. Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature.
Coffey J; Linger R; Pugh J; Dudakia D; Sokal M; Easton DF; Timothy Bishop D; Stratton M; Huddart R; Rapley EA
Genes Chromosomes Cancer; 2008 Jan; 47(1):34-42. PubMed ID: 17943970
[TBL] [Abstract][Full Text] [Related]
11. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
12. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.
Goddard NC; McIntyre A; Summersgill B; Gilbert D; Kitazawa S; Shipley J
Int J Androl; 2007 Aug; 30(4):337-48; discussion 349. PubMed ID: 17573850
[TBL] [Abstract][Full Text] [Related]
13. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.
Kempkensteffen C; Christoph F; Weikert S; Krause H; Köllermann J; Schostak M; Miller K; Schrader M
J Cancer Res Clin Oncol; 2006 Dec; 132(12):765-70. PubMed ID: 16810501
[TBL] [Abstract][Full Text] [Related]
15. A c-KIT codon 816 mutation, D816H, in the testicular germ cell tumor: case report of a Japanese patient with bilateral testicular seminomas.
Tate G; Suzuki T; Kishimoto K; Mitsuya T
Acta Med Okayama; 2005 Feb; 59(1):33-6. PubMed ID: 15902997
[TBL] [Abstract][Full Text] [Related]
16. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of testicular germ cell tumors.
Vilar E; Calvo E; Tabernero J
Clin Transl Oncol; 2006 Dec; 8(12):846-50. PubMed ID: 17169757
[TBL] [Abstract][Full Text] [Related]
18. Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan.
Sakuma Y; Matsukuma S; Yoshihara M; Sakurai S; Nishii M; Kishida T; Kubota Y; Nagashima Y; Inayama Y; Sasaki T; Nakamura Y; Miura T; Kameda Y; Tsuchiya E; Miyagi Y
Cancer Lett; 2008 Jan; 259(1):119-26. PubMed ID: 18006222
[TBL] [Abstract][Full Text] [Related]
19. [Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Kempkensteffen C; Hinz S; Jäger T; Weikert S; Krause H; Schostak M; Christoph F; Strenziok R; Miller K; Schrader M
Aktuelle Urol; 2008 Nov; 39(6):436-41. PubMed ID: 18979398
[TBL] [Abstract][Full Text] [Related]
20. Histopathological and molecular features of late relapses in non-seminomas.
Mayer F; Wermann H; Albers P; Stoop H; Gillis AJ; Hartmann JT; Bokemeyer CC; Oosterhuis JW; Looijenga LH; Honecker F
BJU Int; 2011 Mar; 107(6):936-43. PubMed ID: 20955261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
